v3.25.2
Revenue
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company recorded the following revenues for the three and six months ended June 30, 2025 and 2024 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
ORLADEYO:
U.S.$140,338 $95,909 $260,497 $175,875 
Outside of U.S.16,499 12,379 30,583 21,280 
Total ORLADEYO156,837 108,288 291,080 197,155 
Other revenues6,516 1,044 17,807 4,938 
Total revenues$163,353 $109,332 $308,887 $202,093 
ORLADEYO revenues represent total revenues from product sales, collaborative revenues, and royalties. Other revenues primarily relate to the Company’s product sales and royalties for peramivir.
No individual country outside of the U.S. exceeded 10% of total revenues for the three and six months ended June 30, 2025 and 2024.